In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
3 weeks 6 days ago
4 weeks 6 days ago
5 weeks 7 hours ago
6 weeks 2 days ago
11 weeks 3 days ago
13 weeks 6 days ago
19 weeks 8 hours ago
30 weeks 6 days ago
33 weeks 16 hours ago
34 weeks 17 hours ago